Lipocine Announces Financial Results for the Full Year Ended December 31, 2025

Salt Lake City Archived • March 10, 2026 •

SALT LAKE CITY, March 10, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for the full year ended December 31, 2025 and…

Source: https://www.tremontonleader.com/search/?f=rss&t=article&l=50&c=news* - Read Original

FB X ✉️

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!